Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia

NCT01724359 is registered in ClinicalTrials.gov with Janssen-Cilag, S.A. as lead sponsor.

NCT NCT01724359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01724359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia
Lead sponsor
Janssen-Cilag, S.A.
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2009
Enrollment
95 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia